Physician

Robert B Hegeman, MD

According to 2025 Medicare claims, Robert Hegeman, MD (NPI: 1588630644) practices medical oncology in the Madison, WI market, with the plurality of this provider's patient population coming from Dane, WI. This provider's primary affiliated billing organization is UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION, INC (NPI: 1598784555; TIN: 391824445) and primary practice location at 53901-9271. Hegeman is affiliated with the THEDACARE ACO (ACO ID: A4988) and UW Health ACO, Inc (ACO ID: A5500), participating under the MSSP model.

Hegeman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 427 traditional Medicare patients, billed 64,536 HCPCS/CPT codes, and received $924,711 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,056 prescription claims across 165 beneficiaries totaling $2,034,993 in drug costs, led by Ibrance (Palbociclib). DME data shows 49 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $845,581 to $924,711. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $639,311 to $2,034,993. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$911K$1.8M2015 Medicare payment: $845,581 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $746,546 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $829,174 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $848,945 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $928,706 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,821,466 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,330,360 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $861,727 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,441,307 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $924,711 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201547356,134$845,581
201648646,595$746,546
201750645,255$829,174
201846539,436$848,945
201949154,758$928,706
202048382,627$1,821,466
202151471,121$1,330,360
202248866,106$861,727
202352387,569$1,441,307
202442764,536$924,711

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.0M$2.1M2015 Drug cost: $639,311 (USD; Tot_Drug_Cst)2016 Drug cost: $1,065,909 (USD; Tot_Drug_Cst)2017 Drug cost: $917,182 (USD; Tot_Drug_Cst)2018 Drug cost: $856,004 (USD; Tot_Drug_Cst)2019 Drug cost: $1,441,722 (USD; Tot_Drug_Cst)2020 Drug cost: $2,062,183 (USD; Tot_Drug_Cst)2021 Drug cost: $1,584,994 (USD; Tot_Drug_Cst)2022 Drug cost: $2,042,825 (USD; Tot_Drug_Cst)2023 Drug cost: $1,621,786 (USD; Tot_Drug_Cst)2024 Drug cost: $2,034,993 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151381,029$639,311
20161781,193$1,065,909
20171801,026$917,182
2018151984$856,004
20191571,017$1,441,722
20201691,167$2,062,183
20211841,138$1,584,994
20221581,002$2,042,825
2023170973$1,621,786
20241651,056$2,034,993

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$16K$33K2015 Medicare payment: $32,735 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $15,522 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $9,303 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $11,040 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,325 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $14 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $13 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,395 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $5 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $7 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201525166$32,735
201620150$15,522
20171292$9,303
201812101$11,040
20191584$4,325
20201765$14
20212078$13
20221275$2,395
20231232$5
20241549$7

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more145256$126
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more220302$79
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's261391$11
36415Insertion of needle into vein for collection of blood sample227556$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count84210$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IbrancePalbociclib25693$391,180
RevlimidLenalidomide19529$310,395
JakafiRuxolitinib Phosphate18540$304,876
CalquenceAcalabrutinib Maleate13390$174,789
XtandiEnzalutamide14420$168,929

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0162Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimenN1549$7

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Robert B. Hegeman, MD?

Tedicare shows public-source Medicare data for Robert B. Hegeman, MD (NPI 1588630644), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert B. Hegeman, MD have ACO affiliation data?

Robert B. Hegeman, MD is shown with ACO affiliation data for THEDACARE ACO (MSSP, ACO ID A4988) and UW Health ACO, Inc (MSSP, ACO ID A5500).

What billing organization is linked to Robert B. Hegeman, MD?

Robert B. Hegeman, MD is linked to UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION, INC (billing NPI 1598784555) in the available physician profile data.

Does Robert B. Hegeman, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.